Follow
Dr Thomas Marjot
Dr Thomas Marjot
Verified email at ndm.ox.ac.uk
Title
Cited by
Cited by
Year
Non-alcoholic fatty liver disease and diabetes
JM Hazlehurst, C Woods, T Marjot, JF Cobbold, JW Tomlinson
Metabolism 65 (8), 1096-1108, 2016
5652016
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study
T Marjot, AM Moon, JA Cook, S Abd-Elsalam, C Aloman, MJ Armstrong, ...
Journal of hepatology 74 (3), 567-577, 2021
4702021
COVID-19 and liver disease: mechanistic and clinical perspectives
T Marjot, GJ Webb, AS Barritt IV, AM Moon, Z Stamataki, VW Wong, ...
Nature reviews Gastroenterology & hepatology 18 (5), 348-364, 2021
3512021
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: preliminary results from an international registry
AM Moon, GJ Webb, C Aloman, MJ Armstrong, T Cargill, R Dhanasekaran, ...
Journal of hepatology 73 (3), 705-708, 2020
3062020
Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
GJ Webb, T Marjot, JA Cook, C Aloman, MJ Armstrong, EJ Brenner, ...
The lancet Gastroenterology & hepatology 5 (11), 1008-1016, 2020
2472020
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
T Marjot, A Moolla, JF Cobbold, L Hodson, JW Tomlinson
Endocrine reviews 41 (1), 66-117, 2020
1872020
Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic
T Boettler, T Marjot, PN Newsome, MU Mondelli, M Maticic, E Cordero, ...
JHEP Reports 2 (5), 100169, 2020
1622020
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
T Brevini, M Maes, GJ Webb, BV John, CD Fuchs, G Buescher, L Wang, ...
Nature 615 (7950), 134-142, 2023
1462023
Determining risk factors for mortality in liver transplant patients with COVID-19
GJ Webb, AM Moon, E Barnes, AS Barritt, T Marjot
The Lancet Gastroenterology & Hepatology 5 (7), 643-644, 2020
1102020
SARS-CoV-2 infection in patients with autoimmune hepatitis
T Marjot, G Buescher, M Sebode, E Barnes, AS Barritt IV, MJ Armstrong, ...
Journal of hepatology 74 (6), 1335-1343, 2021
1092021
Genes associated with adult cerebral venous thrombosis
T Marjot, S Yadav, N Hasan, P Bentley, P Sharma
Stroke 42 (4), 913-918, 2011
1042011
PYY plays a key role in the resolution of diabetes following bariatric surgery in humans
C Guida, SD Stephen, M Watson, N Dempster, P Larraufie, T Marjot, ...
EBioMedicine 40, 67-76, 2019
772019
Examining the immunological effects of COVID-19 vaccination in patients with conditions potentially leading to diminished immune response capacity–the OCTAVE trial
P Kearns, S Siebert, C Gaskell, A Kirkham, S Pirrie, S Bowden, ...
692021
Detailed analysis of gene polymorphisms associated with ischemic stroke in South Asians
S Yadav, N Hasan, T Marjot, MS Khan, K Prasad, P Bentley, P Sharma
PloS one 8 (3), e57305, 2013
682013
SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question
T Marjot, GJ Webb, AS Barritt, P Ginès, AW Lohse, AM Moon, E Pose, ...
The Lancet Gastroenterology & Hepatology 6 (3), 156-158, 2021
602021
A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health
A Moolla, K Motohashi, T Marjot, A Shard, M Ainsworth, A Gray, R Holman, ...
Frontline gastroenterology 10 (4), 337-346, 2019
592019
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
T Marjot, CS Eberhardt, T Boettler, LS Belli, M Berenguer, M Buti, R Jalan, ...
Journal of hepatology 77 (4), 1161-1197, 2022
582022
COVID-19 and liver disease
JF Dufour, T Marjot, C Becchetti, H Tilg
Gut 71 (11), 2350-2362, 2022
552022
Mapping tissue water T1 in the liver using the MOLLI T1 method in the presence of fat, iron and B0 inhomogeneity
FE Mozes, EM Tunnicliffe, A Moolla, T Marjot, CK Levick, M Pavlides, ...
NMR in Biomedicine 32 (2), e4030, 2019
532019
Prevalence and severity of non‐alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching …
T Marjot, E Sbardella, A Moolla, JM Hazlehurst, GD Tan, M Ainsworth, ...
Diabetic Medicine 35 (1), 89-98, 2018
462018
The system can't perform the operation now. Try again later.
Articles 1–20